Innovex International vs Cactus
INVX and WHD side by side, both in construction, mining, and materials handling. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INVX and WHD compare
Cactus is the larger company, worth 2.8 times as much as Innovex International ($5.0B against $1.8B).
Cactus grew revenue faster over the last twelve months (40.4% versus 7.0% for Innovex International).
Cactus keeps more of each dollar of sales as profit, with a net margin of 12.0% compared with 4.8% at Innovex International.
Cactus pays a dividend yielding 0.92%; Innovex International does not pay one.
Cactus scores higher on the StockData Score (16 against 9 for Innovex International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INVX | WHD |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $5.0B |
| Share price | $25.04 | $61.75 |
| Change, 1 year | 22.0% | 43.0% |
| Change, 5 years | 28.5% | 63.4% |
| Beta (5Y) | 0.85 | 1.20 |
| Employees | 2,160 | 1,500 |
| StockData Score | ||
| Total score | 9 | 16 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 | 4 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 36.3× | – |
| P/S | 1.7× (better) | 3.2× |
| P/B | 1.6× (better) | 3.8× |
| EV/EBITDA | 11.8× (better) | 11.9× |
| Fair value | $20.11 | $48.00 |
| Margin of safety | −24.5% (better) | −28.6% |
| Growth | ||
| Revenue growth (TTM) | 7.0% | 40.4% (better) |
| Revenue growth, 5Y average | 21.8% | 25.4% (better) |
| Net income growth (TTM) | −51.9% | 6.4% (better) |
| EPS growth (TTM) | −48.1% | – |
| Profitability | ||
| Gross margin | 33.6% (better) | 33.5% |
| Operating margin | 6.9% | 18.8% (better) |
| Net margin | 4.8% | 12.0% (better) |
| Return on equity | 4.5% | 14.7% (better) |
| Return on invested capital | 4.9% | 26.0% (better) |
| Financial health | ||
| Debt / equity | 0.02 (better) | 0.00 |
| Net debt / EBITDA | −1.22 | – |
| Interest coverage | 19.1× | – |
| Current ratio | 4.43 (better) | 3.06 |
| Altman Z-score | 5.25 | 5.43 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.92% |
| Payout ratio | – | 21.8% |
| Years of dividend growth | – | 6 |
| Dividend growth, 5Y average | – | 8.4% |
| Buyback yield | 0.81% (better) | 0.16% |
| Shareholder yield | 0.81% | 1.1% (better) |
| Ownership | ||
| Held by institutions | 73.5% | 95.7% |
| Held by insiders | – | 14.4% |
| Insider net buying, 12 months | −$615M | −$90.1M (better) |
| Short interest, % of float | – | 4.3% |
Go deeper
- INVX stock overview
- INVX income statement
- INVX valuation and score
- WHD stock overview
- WHD income statement
- WHD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.